Characterization of the angiotensin II receptor, J.Marie et al; the difficult challenge of cloning the angiotensin II receptor, V.Weber et al; mode of action of angiotensin II and vasopressin on their target cells, M.B.Vallotton et al; glucocorticoids in blood pressure regulation, J.P.Grunfeld; renal 11-beta-hydroxysteroid dehydrogenase - a mechanism ensuring mineralocorticoid specificity, C.R.W.Edwards; a unifying hypothesis of sodium and water regulation in health and disease, R.L.Howard and R.W.Schrier; vasopressin agonists and antagonists, M.Thibonnier; kappa agonists and vasopressin secretion, G.Hamon and S.Jouquey; current indication of plasma atrial natriuretic peptide measurements in human diseases, J.C.Dussaule and R.Ardaillou; immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure and liver cirrhosis, P.F.Plouin et al; plasma levels of aldosterone precursors, including the 18-hydroxylated compounds in this synthesis pathway - a tool for the analysis of adrenal disorders?, B.Aupetit-Faisant; neurophysins as markers of vasopressin and oxytocin release - a study in carcinoma of the lung, J.J.Legros et al; catecholamines and blood pressure regulation, M.Mannelli et al; role of atrial natriuretic peptides and neuropeptide Y in blood pressure regulation, B.Waeber et al; atrial natriuretic factor as a marker in congestive heart failure, J.B.Michel et al; endothelin, P.E.Chabrier and P.Braquet; new aspects of mineralocorticoid hypertension, F.Mantero et al.
